-

Tokens.com Announces Date for Q2 2021 Financial Results and Investor Call

TORONTO--(BUSINESS WIRE)--Tokens.com Corp. (NEO:COIN) (FSE:76M) (“Tokens.com” or the “Company”), a publicly traded company that uses shareholder capital to invest in digital assets used for crypto staking and Decentralized Finance (DeFi), will announce its financial results for its second quarter ended June 30, 2021 (“Q2 2021”) on Friday August 13, 2021.

An investor call hosted by CEO Andrew Kiguel has been scheduled to discuss the Company’s Q2 2021 financial results starting at 10:00 am ET on Friday August 13, 2021.

Date: Friday August 13, 2021
Time: 10:00 a.m. ET
Dial-In: 1 (888) 465-5079
Passcode: 7539 632#

About Tokens.com

Tokens.com is a publicly traded blockchain technology company that connects investors to the digital assets used for crypto staking and Decentralized Finance (DeFi). To accomplish this, Tokens utilizes Proof-of-Stake (“PoS”) or Staking technology. DeFi is a new class of financial applications that provides users with automated and transparent financial services, such as borrowing and lending, without the need for financial institutions. Management believes that as mainstream adoption for DeFi applications grows, the need for Tokens.com’s staking services will commensurately increase.

Tokens’ management team includes seasoned blockchain and financial professionals with prior experience at Hut 8 Mining, Fidelity Investments, Galaxy Digital and Goldman Sachs. Current investors include Bitbuy Limited, First Block Capital, HIVE Blockchain Technologies Ltd., PowerOne Capital Group, Matthew Roszak (Co-founder and Chairman of Bloq, Inc.), and Olaf Carlson-Wee (Founder and CEO of Polychain Capital).

The Company’s common shares are listed under the symbol “COIN” in Canada on the NEO Exchange, as “76M” on the Frankfurt Stock Exchange and as “SMURF” on the U.S. OTC Market.

Further information can be found on the Company’s website: Tokens.com.

Keep up-to-date on Tokens.com developments and join our online communities at Twitter, LinkedIn, and YouTube.

Contacts

Tokens.com Corp.
Katherine Sullivan, Head of Corporate Strategy & Investor Relations
contact@tokens.com
(647) 578-7490

Media: Megan Stangl – Talk Shop Media
Megan@talkshopmedia.com

Tokens.com Corp.

NEO:COIN

Release Versions

Contacts

Tokens.com Corp.
Katherine Sullivan, Head of Corporate Strategy & Investor Relations
contact@tokens.com
(647) 578-7490

Media: Megan Stangl – Talk Shop Media
Megan@talkshopmedia.com

More News From Tokens.com Corp.

Realbotix Relaunched Ask Aria Digital AI Avatar

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a developer of humanoid robots and AI systems, today announced the relaunch of Ask Aria, its interactive online AI experience. The AI powering Ask Aria is the same conversational technology used in Realbotix’s new Echo humanoid robots. The upgraded experience features enhanced expressiveness and improved conversational intelligence.Ask Aria is an AI-powered digital 3D avatar...

Realbotix Launches Echo Humanoid Robot Line

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a manufacturer of humanoid robots and AI systems, announces the launch of its new flagship robot platform, Echo. Designed for companionship, education, and wellness, Echo robots are built to support meaningful human-to-robot interaction. Its streamlined modular architecture makes it easy for customers to configure robots that deliver practical value in social and personal e...

Realbotix Announces Additional Draw under Bridge Loan from Onconetix

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has agreed to an additional advance of US$500,000 in connection with the loan agreement entered into with Onconetix, Inc. (“Onconetix”) on September 14, 2026 in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on...
Back to Newsroom